183 related articles for article (PubMed ID: 32611642)
1. Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy.
Dahlqvist JR; Poulsen NS; Østergaard ST; Fornander F; de Stricker Borch J; Danielsen ER; Thomsen C; Vissing J
Neurology; 2020 Sep; 95(9):e1211-e1221. PubMed ID: 32611642
[TBL] [Abstract][Full Text] [Related]
2. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy.
Dahlqvist JR; Andersen G; Khawajazada T; Vissing C; Thomsen C; Vissing J
J Neurol; 2019 May; 266(5):1127-1135. PubMed ID: 30778707
[TBL] [Abstract][Full Text] [Related]
3. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
4. Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients.
Janssen B; Voet N; Geurts A; van Engelen B; Heerschap A
Neurology; 2016 May; 86(18):1700-7. PubMed ID: 27037227
[TBL] [Abstract][Full Text] [Related]
5. MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.
Ferguson MR; Poliachik SL; Budech CB; Gove NE; Carter GT; Wang LH; Miller DG; Shaw DWW; Friedman SD
Muscle Nerve; 2018 Jun; 57(6):905-912. PubMed ID: 29236297
[TBL] [Abstract][Full Text] [Related]
6. Quantitative
Gerhalter T; Marty B; Gast LV; Porzelt K; Heiss R; Uder M; Schwab S; Carlier PG; Nagel AM; Türk M
J Neurol; 2021 Mar; 268(3):1076-1087. PubMed ID: 33047224
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH; Shaw DWW; Faino A; Budech CB; Lewis LM; Statland J; Eichinger K; Tapscott SJ; Tawil RN; Friedman SD
BMC Musculoskelet Disord; 2021 Mar; 22(1):262. PubMed ID: 33691664
[TBL] [Abstract][Full Text] [Related]
8. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
Hamel J; Lee P; Glenn MD; Burka T; Choi IY; Friedman SD; Shaw DWW; McCalley A; Herbelin L; Dimachkie MM; Lemmers R; van der Maarel SM; Barohn RJ; Tawil R; Statland JM
Muscle Nerve; 2020 May; 61(5):644-649. PubMed ID: 31884698
[TBL] [Abstract][Full Text] [Related]
10. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.
Rijken NH; van der Kooi EL; Hendriks JC; van Asseldonk RJ; Padberg GW; Geurts AC; van Engelen BG
Neuromuscul Disord; 2014 Dec; 24(12):1087-96. PubMed ID: 25176503
[TBL] [Abstract][Full Text] [Related]
12. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.
Dahlqvist JR; Vissing CR; Thomsen C; Vissing J
Neurology; 2014 Sep; 83(13):1178-83. PubMed ID: 25142899
[TBL] [Abstract][Full Text] [Related]
13. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E
PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944
[TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
15. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
[TBL] [Abstract][Full Text] [Related]
16. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
18. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
[TBL] [Abstract][Full Text] [Related]
19. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.
Fischer D; Hafner P; Rubino D; Schmid M; Neuhaus C; Jung H; Bieri O; Haas T; Gloor M; Fischmann A; Bonati U
Neuromuscul Disord; 2016 Jul; 26(7):414-22. PubMed ID: 27209345
[TBL] [Abstract][Full Text] [Related]
20. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
